NervGen Pharma (NGEN) vs Oramed Pharmaceuticals (ORMP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Oramed Pharmaceuticals (ORMP) has outperformed NervGen Pharma (NGEN) over the past year, gaining 76.2% versus a loss of 44.1%. Over five years, NGEN leads with a -7.9% price change compared with -80.2% for ORMP. NervGen Pharma is the larger company by market cap ($187.1 million vs $181.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NGEN | ORMP |
|---|---|---|
| Share price | $1.74 | $4.37 |
| Market cap | $187.09M | $181.78M |
| 1-day change | -0.57% | -0.23% |
| YTD return | -68.93% | +53.33% |
| 1-year return | -44.12% | +76.21% |
| 5-year return | -7.94% | -80.19% |
| P/E ratio (TTM) | — | 1.06 |
| EPS (TTM) | $-0.57 | $4.13 |
| Dividend yield | 0.00% | 5.70% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.30 | $5.47 |
| 52-week low | $1.58 | $2.09 |
| Distance from 52-week high | -72.38% | -20.11% |
| Average volume | 578.27K | 194.48K |
| Shares outstanding | 107.52M | 41.60M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ORMP has outperformed NGEN by 120.3 percentage points over the past year.
- Oramed Pharmaceuticals offers a meaningfully higher dividend yield (5.70% vs 0.00%).
NGEN vs ORMP FAQ
Which is bigger, NervGen Pharma or Oramed Pharmaceuticals?
NervGen Pharma (NGEN) is larger, with a market capitalization of $187.09M compared with $181.78M for Oramed Pharmaceuticals (ORMP).
Which stock has performed better over the past year, NGEN or ORMP?
ORMP returned +76.21% over the past 12 months, compared with -44.12% for NGEN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, NervGen Pharma or Oramed Pharmaceuticals?
Oramed Pharmaceuticals pays a dividend yielding 5.70%, while NervGen Pharma does not currently pay a regular dividend.
Are NervGen Pharma and Oramed Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.